BROWN CAPITAL MANAGEMENT LLC 13D and 13G filings for Cytek Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 1:42 pm Sale | 2024-09-30 | 13G | Cytek Biosciences, Inc. CTKB | BROWN CAPITAL MANAGEMENT LLC | 9,493,474 7.220% | -2,522,851 (-21.00%) | Filing |
| 2024-02-14 3:12 pm Purchase | 2023-12-31 | 13G | Cytek Biosciences, Inc. CTKB | BROWN CAPITAL MANAGEMENT LLC | 12,016,325 8.860% | 12,016,325 (New Position) | Filing |